MaxWell Biosystems provides solutions to advance basic neuroscience research and accelerate preclinical drug discovery.
MaxWell Biosystems's investors include Venture Kick, EISMEA, Technology Fund, Sensirion.
MaxWell Biosystems is headquartered in Basel, Switzerland.
MaxWell Biosystems provides solutions to advance basic neuroscience research and accelerate preclinical drug discovery.
MaxWell Biosystems is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MaxWell Biosystems — Funding & Investors." VCBacked, December 10, 2021, https://www.vcbacked.co/company/maxwell-biosystems. Accessed September 30, 2026.
VCBacked. (2021). MaxWell Biosystems — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/maxwell-biosystems
{{cite web |title=MaxWell Biosystems — Funding & Investors |url=https://www.vcbacked.co/company/maxwell-biosystems |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated